#gip
2 articles tagged with #gip
Research & Science
Tirzepatide vs Semaglutide — Dual vs Single Incretin Research
Tirzepatide and Semaglutide are the two most-studied incretin research peptides, but they target different receptor profiles. This head-to-head explains what GIP-receptor activation adds to a GLP-1 base, why Tirzepatide is GIP-biased, and how the two compounds compare in research applications.
Admin•4 min
Research & Science
Retatrutide — Triple GLP-1/GIP/Glucagon Agonist Research Review
Retatrutide is the first triple agonist of GLP-1, GIP, and glucagon receptors to enter major incretin research. This review walks through its mechanism — what each receptor arm contributes, why glucagon-receptor activation matters, and how the triple-receptor profile compares to dual-incretin compounds.
Admin•4 min